info on semaglutide FDA Approves Oral Semaglutide: First GLP-1 Weight Loss Pill Semaglutide, also known as Ozempic,

Nausea and vomiting appear to be most common when people overeat or potentially overeat fat which also slows down gastric emptying and could further worsen symptoms

Less common but serious concerns - Acute pancreatitis has been reported with GLP-1 RAs

Theres no evidence from human clinical trials that NAC causes cancer

In clinical trials, the weight loss curve is not a straight line

Modest ketosis with adequate protein is more valuable for body composition than deep ketosis with inadequate protein

Comparison Table: Retatrutide vs Tirzepatide Side Effects and Safety Profile Common Side Effects (Both Medications) Both tirzepatide and retatrutide share a similar gastrointestinal side effect profile, which is characteristic of incretin-based therapies: Nausea (most common, typically transient) Diarrhea Constipation Vomiting Decreased appetite Abdominal discomfort Fatigue These effects are generally mild to moderate and tend to diminish as the body adjusts to the medication, particularly when doses are titrated gradually